Search Results - "Woelber, L"

Systematic review – Adjuvant radiotherapy of the vulva in primary vulvar cancer by Proppe, L., Jaeger, A., Goy, Y., Petersen, C., Kruell, A., Prieske, K., Schmalfeldt, B., Mueller, V., Woelber, L.

“…Adjuvant radiotherapy to the vulva in vulvar squamous cell carcinoma (VSCC) is frequently performed albeit strong evidence is lacking. This systematic review…”
Get full text

The use of colposcopy for triage in HPV-positive women aged 65 years and older by Kuenkel, E., Jaeger, A., Bohlmann, I., Bergauer, F., Kuehler-Obbarius, C., Prieske, K., Maass-Poppenhusen, K., Schmalfeldt, B., Woelber, L.

“…Purpose Persistent high-risk HPV infection is associated with an elevated risk for prevalent CIN II + despite normal cytology (NILM). Our study aims to…”
Get full text

Pelvic lymphadenectomy in vulvar cancer and its impact on prognosis and outcome by Jaeger, A., Prieske, K., Mathey, S., Fischer, I., Vettorazzi, E., Kuerti, S., Reuter, S., Dieckmann, J., Schmalfeldt, B., Woelber, L.

“…Background The value of pelvic lymphadenectomy (LAE) has been subject of discussions since the 1980s. This is mainly due to the fact that the relation between…”
Get full text

Genomic characterization of vulvar squamous cell carcinoma by Prieske, K., Alawi, M., Joosse, S.A., Eylmann, K., Burandt, E., Schmalfeldt, B., Oliveira-Ferrer, L., Woelber, L.

Get full text

Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study by Trillsch, F., Mahner, S., Woelber, L., Vettorazzi, E., Reuss, A., Ewald-Riegler, N., de Gregorio, N., Fotopoulou, C., Schmalfeldt, B., Burges, A., Hilpert, F., Fehm, T., Meier, W., Hillemanns, P., Hanker, L., Hasenburg, A., Strauss, H.G., Hellriegel, M., Wimberger, P., Baumann, K., Keyver-Paik, M.D., Canzler, U., Wollschlaeger, K., Forner, D., Pfisterer, J., Schroeder, W., Muenstedt, K., Richter, B., Kommoss, F., Hauptmann, S., du Bois, A.

“…Approximately one-third of all borderline ovarian tumours (BOT) are diagnosed in patients with child-bearing potential. Detailed information regarding their…”
Get full text

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study by Trillsch, F, Mahner, S, Vettorazzi, E, Woelber, L, Reuss, A, Baumann, K, Keyver-Paik, M-D, Canzler, U, Wollschlaeger, K, Forner, D, Pfisterer, J, Schroeder, W, Muenstedt, K, Richter, B, Fotopoulou, C, Schmalfeldt, B, Burges, A, Ewald-Riegler, N, de Gregorio, N, Hilpert, F, Fehm, T, Meier, W, Hillemanns, P, Hanker, L, Hasenburg, A, Strauss, H-G, Hellriegel, M, Wimberger, P, Kommoss, S, Kommoss, F, Hauptmann, S, du Bois, A

“…Background: Incomplete surgical staging is a negative prognostic factor for patients with borderline ovarian tumours (BOT). However, little is known about the…”
Get full text

Preoperative c-reactive protein and thrombocyte count as potential markers for longterm survival in ovarian cancer by Braicu, E.I., Sehouli, J., Richter, R., Vergote, I.B., Concin, N., van Nieuwenhuysen, E., Achimas, P., Berger, A., Fetica, B., Mahner, S., Glajzer, J., Papadia, A., Woelber, L., Gasparri, M.L., Vanderstichele, A., Benedetti Panici, P., Mueller, M., Ruscito, I., Zimmer, J., Woopen, H.

Get full text

EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome by Woelber, L, Hess, S, Bohlken, H, Tennstedt, P, Eulenburg, C, Simon, R, Gieseking, F, Jaenicke, F, Mahner, S, Choschzick, M

“…EGFR copy number increases have been frequently reported in cancer including vulvar carcinomas. Co-amplification of cancer genes plays an important role in the…”
Get more information

Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer by Woelber, L, Jung, S, Eulenburg, C, Mueller, V, Schwarz, J, Jaenicke, F, Mahner, S

“…Abstract Background Despite radical surgical and chemotherapeutic treatment of ovarian cancer, the majority of patients develop recurrent disease. Secondary…”
Get full text

BIRC2 amplification in squamous cell carcinomas of the uterine cervix by Choschzick, M., Tabibzada, A. M., Gieseking, F., Woelber, L., Jaenicke, F., Sauter, G., Simon, R.

“…Oncogene amplification is a key step in cell transformation towards malignancy. Chromosomal aberrations involving the long arm of chromosome 11, including…”
Get full text

Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva by Schwegler, J, Schwarz, J, Eulenburg, C, Blome, C, Ihnen, M, Mahner, S, Jaenicke, F, Augustin, M, Woelber, L

“…This study investigates the health-related quality of life in patients with vulvar lichen sclerosus (LS) and the patient-defined therapeutic benefit of…”
Get more information

OC-0363: Impact of adjuvant therapy in lymph-node positive vulvar cancer- The AGO-CaRe 1 (Chemo- and Radiotherapy) study by Petersen, C, Woelber, L, Jueckstock, J, Hilpert, F, Neuser, P, Harter, P, De Gregorio, N, Hasenburg, A, Sehouli, J, Mahner, S

Get full text

Das Vulvakarzinomrezidiv: eine besondere Herausforderung by Woelber, L., Prieske, K.

“…Zusammenfassung Der wichtigste prognostische Faktor für das Auftreten eines Rezidivs ist das Vorliegen von inguinalen Lymphknotenmetastasen bei Erstdiagnose…”
Get full text

Number of metastatic lymph nodes and locoregional control in vulvar cancer by Mahner, S, Choschzik, M, Eulenburg, C, Hager, M, Gieseking, F, Schwarz, J, Jaenicke, F, Woelber, L

Get full text

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study by Coleman, Robert L, Lorusso, Domenica, Gennigens, Christine, González-Martín, Antonio, Randall, Leslie, Cibula, David, Lund, Bente, Woelber, Linn, Pignata, Sandro, Forget, Frederic, Redondo, Andrés, Vindeløv, Signe Diness, Chen, Menghui, Harris, Jeffrey R, Smith, Margaret, Nicacio, Leonardo Viana, Teng, Melinda S L, Laenen, Annouschka, Rangwala, Reshma, Manso, Luis, Mirza, Mansoor, Monk, Bradley J, Vergote, Ignace, Raspagliesi, Francesco, Melichar, Bohuslav, Gaba Garcia, Lydia, Jackson, Amanda, Henry, Stephanie, Kral, Zdenek, Harter, Philipp, De Giorgi, Ugo, Bjurberg, Maria, Gold, Michael, O'Malley, David, Honhon, Brigitte, Vulsteke, Christof, De Cuypere, Eveline, Denys, Hannelore, Baurain, Jean-Francois, Zamagni, Claudio, Tenney, Meaghan, Gordinier, Mary, Bradley, William, Schlumbrecht, Matthew, Spirtos, Nicola, Concin, Nicole, Mahner, Sven, Scambia, Giovanni, Leath, Charles, Farias-Eisner, Robin, Cohen, Joshua, Muller, Carolyn, Bhatia, Sumeet

“…Few effective second-line treatments exist for women with recurrent or metastatic cervical cancer. Accordingly, we aimed to evaluate the efficacy and safety of…”
Get full text

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women by Joura, Elmar A, Giuliano, Anna R, Iversen, Ole-Erik, Bouchard, Celine, Mao, Constance, Mehlsen, Jesper, Moreira, Edson D, Ngan, Yuen, Petersen, Lone Kjeld, Lazcano-Ponce, Eduardo, Pitisuttithum, Punnee, Restrepo, Jaime Alberto, Stuart, Gavin, Woelber, Linn, Yang, Yuh Cheng, Cuzick, Jack, Garland, Suzanne M, Huh, Warner, Kjaer, Susanne K, Bautista, Oliver M, Chan, Ivan S.F, Chen, Joshua, Gesser, Richard, Moeller, Erin, Ritter, Michael, Vuocolo, Scott, Luxembourg, Alain

“…The quadrivalent human papillomavirus vaccine is effective in preventing infection and disease related to HPV types 6, 11, 16, and 18. This phase 3 trial…”
Get full text

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial by Gladieff, Laurence, Martínez-García, Jerónimo, Villacampa, Guillermo, Takekuma, Munetaka, De Giorgi, Ugo, Lindemann, Kristina, Woelber, Linn, Colombo, Nicoletta, Duska, Linda, Leary, Alexandra, Godoy-Ortiz, Ana, Angelergues, Antoine, Rubio, Maria Jesús, Fariñas-Madrid, Lorena, Lorusso, Domenica, Ray-Coquard, Isabelle, Manso, Luis, Joly, Florence, Alarcón, Jesús, Follana, Philippe, Romero, Ignacio, Lebreton, Coriolan, Pérez-Fidalgo, J Alejandro, Yunokawa, Mayu, Dahlstrand, Hanna, Abadie-Lacourtoisie, Sophie, Anzizar, Nerea, Aoki, Daiseuke, Barretina-Ginesta, Maria-Pilar, Battista, Marco, Bentzen, Anne Gry, Berton, Dominique, Bjørge, Line, Bjurberg, Maria, Bologna, Alessandra, Casanova, Claudia, Chekerov, Radoslav, Chevalier, Annick, Cueva, Juan Fernando, Czogalla, Bastian, Delanoy, Nicolas, Denschlag, Dominik, Derke, Oscar, Eichbaum, Michael, Enomoto, Takayuki, Esteban, Carmen, Fabbro, Michel, Fehm, Tanja, Ferrero, Annamaria, Fleisch, Markus, Floquet, Anne, Frassoldati, Antonio, Gaba, Lydia, Gadducci, Angiolo, García, Yolanda, Geuna, Elena, Hanker, Lars, Hardy-Bessard, Anne-Claire, Harter, Philipp, Hasegawa, Kosei, Hellman, Kristina, Herrero, Ana, Hilpert, Felix, Katsaros, Dionyssios, Koegel, Matthias, Koliadi, Anthoula, Kurtz, Jean-Emmanuel, Lampe, Bjoern, Lissoni, Andrea Alberto, Lortholary, Alain, Mangili, Giorgia, Mansi, Laura, Marmé, Frederik, Mathews, Cara, Mina, William, Nagao, Shoji, Nishino, Koji, Nishio, Hiroshi, Nishio, Shin, Oaknin, Ana, Onstad, Michaela, Pardo, Beatriz, Pisano, Carmela, Poveda, Andrés, Radosa, Julia, Randall, Leslie M., Ray-Coquard, Isabelle, Richardson, Debra, Romero, Ignacio, Ronzino, Graziana, Rubio, Maria Jesús, Selle, Frederic, Takekuma, Munetaka, Takeshima, Nobuhiro, Tewari, Krishnansu, Todo, Yukiharu, Wimberger, Pauline, Woelber, Linn, You, Benoît, Yunokawa, Mayu

“…The GOG240 trial established bevacizumab with chemotherapy as standard first-line therapy for metastatic or recurrent cervical cancer. In the BEATcc trial…”
Get full text

European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023 by Oonk, Maaike H M, Planchamp, François, Baldwin, Peter, Mahner, Sven, Mirza, Mansoor Raza, Fischerová, Daniela, Creutzberg, Carien L, Guillot, Eugénie, Garganese, Giorgia, Lax, Sigurd, Redondo, Andres, Sturdza, Alina, Taylor, Alexandra, Ulrikh, Elena, Vandecaveye, Vincent, van der Zee, Ate, Wölber, Linn, Zach, Diana, Zannoni, Gian Franco, Zapardiel, Ignacio

“…As part of its mission to improve the quality of care for women with gynecological cancers across Europe, the European Society of Gynaecological Oncology…”
Get more information

561P When to treat the pelvis in node-positive vulvar cancer: Results from the AGO-VOP.2 QS vulva study by Hampl, M., Jaeger, A., Eulenburg, C., Prieske, K., Hambrecht, J., Fuerst, S., Klapdor, R., Heublein, S., Gass, P., Rohner, A., Canzler, U., Becker, S., Bommert, M., Bauerschlag, D., Denecke, A., Hanker, L., Sehouli, J., Dannecker, C., Mahner, S., Woelber, L.

Get full text

533P Real-world data of treatment and outcome of patients with relapsed ovarian cancer (OC) in Germany (QS ovar of the AGO study group) by Harter, P., du Bois, A., Hilpert, F., Kerkmann, M., Sehouli, J., Mahner, S., de Gregorio, N., Hanker, L., Heitz, F., Marmé, F., Woelber, L., Holtmann, L., Elser, G., Pfisterer, J.

Get full text